Thursday, January 28, 2027 at 4:40 PM to 5:10 PM · 30 min. (Europe/London)
AI in Drug Discovery Stage
Day 2 - Thursday 28th January
AIAI in Drug DiscoveryDrug DiscoveryMulti-Omics
Information
Explore how machine learning applied to large-scale plasma proteomics datasets can identify clinically meaningful disease segments and patient subtypes that are not captured by traditional diagnostic approaches.
Demonstrate how proteomic signatures can be used to characterise disease heterogeneity, improve patient stratification, and support earlier diagnosis and precision medicine decision-making.